Securities code: 002826 stock abbreviation: Tibet Aim Pharm.Inc(002826) Announcement No.: 2022-009 Tibet Aim Pharm.Inc(002826)
Announcement of the resolution of the first extraordinary general meeting of shareholders in 2022
The company and all members of the board of directors guarantee that the information disclosed is true, accurate and complete without false records, misleading statements or major omissions. Special tips: 1. There is no proposal to add, veto or change at this shareholders’ meeting. 2. This shareholders’ meeting does not involve any proposal to change the resolution of the previous shareholders’ meeting.
1、 Meeting held:
1. Notice of the meeting: Tibet Aim Pharm.Inc(002826) (hereinafter referred to as “the company” or ” Tibet Aim Pharm.Inc(002826) “) the board of directors on January 19, 2022 in Shanghai Securities News, securities times and cninfo (www.cn. Info. Com. CN.) The notice on convening the first extraordinary general meeting of shareholders in 2022 was disclosed.
2. Meeting time:
(1) On site meeting time: 14:30 p.m. on Wednesday, February 16, 2022;
(2) Online voting time: the specific time of online voting through the trading system of Shenzhen stock exchange is 9:15-9:25 a.m., 9:30-11:30 p.m. and 13:00-15:00 p.m. on February 16, 2022; The specific time of online voting through the Internet voting system of Shenzhen stock exchange is any time from 9:15 a.m. on February 16, 2022 to 15:00 p.m. on February 16, 2022.
3. Venue of the on-site meeting: 4-15a, block C, Yingdu building, a48 Zhichun Road, Haidian District, Beijing. 4. Convener of the meeting: the third board of directors of the company.
5. Voting method at the meeting: combination of on-site open written voting and online voting.
6. Host of the on-site meeting: Mr. Peng Hui, chairman.
7. Equity registration date: February 10, 2022
8. The time, place, method, convener, host, and convening and convening procedures of this general meeting of shareholders are in accordance with the provisions of the company law, the securities law, the Listing Rules of Shenzhen Stock Exchange and other laws, administrative regulations, departmental rules, normative documents and the articles of association of the company.
2、 Attendance at the meeting
A total of 11 shareholders attended the general meeting, with 80229760 representative shares, accounting for 41.9633% of the total shares of the listed company, including:
1. A total of 8 shareholders and shareholder representatives attended the on-site meeting of the general meeting of shareholders, all of whom were registered in Shenzhen Branch of China Securities Depository and Clearing Co., Ltd. after the closing of the market on February 10, 2022 and went through the registration procedures for attending the meeting. The number of voting shares of shareholders’ representatives present at the scene was 76496402, accounting for 40.0106% of the total number of Tibet Aim Pharm.Inc(002826) shares. Among them, Gao fan entrusted permission to vote on his behalf, and the number of entrusted shares was 50971482.
2. According to the statistical results of online voting provided by Shenzhen Securities Information Co., Ltd., three shareholders participated in the voting within the online voting time specified in the notice of the general meeting of shareholders, representing 3733358 shares, accounting for 1.9527% of the total shares of the company.
The company’s directors, supervisors and Secretary of the board of directors attended the shareholders’ meeting, and other senior managers attended the shareholders’ meeting as nonvoting delegates. Beijing Zhide law firm appointed lawyers to attend and witness the meeting.
3、 Deliberation and voting of proposals
The shareholders’ meeting deliberated and voted on the following matters through on-site voting:
Proposal 1: the proposal on regulating the registration items of the business scope of the company’s business license and revising the articles of association accordingly was deliberated and adopted
Total voting:
Agree to 80229760 shares, accounting for 100.0000% of the shares held by all shareholders attending the meeting; 0 dissenting shares, accounting for 0.0000% of the shares held by all shareholders attending the meeting; Abstain 0 shares (including 0 shares by default due to non voting), accounting for 0.0000% of the shares held by all shareholders attending the meeting.
Total voting of minority shareholders:
Agree to 9770439 shares, accounting for 100.0000% of the shares held by minority shareholders attending the meeting; 0 opposition shares, accounting for 0.0000% of the shares held by minority shareholders attending the meeting; Abstain from 0 shares (including 0 shares by default due to non voting), accounting for 0.0000% of the shares held by minority shareholders attending the meeting.
4、 Legal opinions issued by lawyers
The meeting was witnessed by the lawyer of Beijing Zhide law firm. The legal opinion issued by him believes that the convening and convening procedures of the general meeting of shareholders comply with the provisions of relevant laws, administrative regulations, normative documents and Tibet Aim Pharm.Inc(002826) articles of Association; The qualifications of the convener and attendees of the general meeting of shareholders are legal and valid; The voting procedures and methods of this general meeting of shareholders comply with the provisions of relevant laws, administrative regulations, normative documents and Tibet Aim Pharm.Inc(002826) articles of association, and the voting results are legal and valid.
5、 Documents for future reference
1. The resolution of Tibet Aim Pharm.Inc(002826) the first extraordinary general meeting of shareholders in 2022 signed by the attending directors;
2. Legal opinion issued by Beijing Zhide law firm for this extraordinary general meeting of shareholders.
It is hereby announced.
Tibet Aim Pharm.Inc(002826) board of directors
February 16, 2002
